Zhengtao Chu

661 Huanghe 2nd Rd
Binzhou, 256603, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles.

Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles.

Journal: Cells

Published: July 26, 2020

Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease.

Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease.

Journal: EBioMedicine

Published: November 06, 2019

Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer.

Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: September 18, 2019

Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles.

Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles.

Journal: Oncotarget

Published: August 15, 2018

Utility of arterial spin labelling MRI for discriminating atypical high-grade glioma from primary central nervous system lymphoma.

Utility of arterial spin labelling MRI for discriminating atypical high-grade glioma from primary central nervous system lymphoma.

Journal: Clinical radiology

Published: February 02, 2018

mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors that Progress on Rapalog Therapy and Delays Cardiac Impairment.

mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors that Progress on Rapalog Therapy and Delays Cardiac Impairment.

Journal: Molecular cancer therapeutics

Published: January 18, 2017

PLK1 inhibition enhances temozolomide efficacy in IDH1 mutant gliomas.

PLK1 inhibition enhances temozolomide efficacy in IDH1 mutant gliomas.

Journal: Oncotarget

Published: September 09, 2016

Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium.

Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium.

Journal: Oncotarget

Published: August 27, 2015

Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma.

Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma.

Journal: Oncotarget

Published: August 25, 2015

Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles.

Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles.

Journal: Oncotarget

Published: June 25, 2015

SapC-DOPS nanovesicles as targeted therapy for lung cancer.

SapC-DOPS nanovesicles as targeted therapy for lung cancer.

Journal: Molecular cancer therapeutics

Published: February 12, 2015

Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles.

Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles.

Journal: Translational oncology

Published: January 15, 2015

Showing 1-12 of 22

Last Updated: 09/26/2026